As obesity and type 2 diabetes are closely connected with NAFLD, the findings obtained in obese and/or diabetic patients, in which MAIT cells are less abundant in blood and produce IL-17 in adipose tissue, will possibly also reflect changes associated with fatty liver disease [92]. This evidence concerns the gene IL17A and metabolic dysfunction-associated steatotic liver disease.